Bodal Chemicals Q1FY27 net profit surges 179% on strong volumes
Bodal Chemicals delivered strong Q1FY27 results with standalone net profit rising 179% YoY to ₹287.83 million on robust revenue growth of 56%. Consolidated PAT increased to ₹303.79 million, driven by improved realizations in key segments like Dye Intermediates and Basic Chemicals, despite margin pressure from raw material costs.
*this image is generated using AI for illustrative purposes only.
Bodal Chemicals reported a sharp acceleration in profitability for the quarter ended June 30, 2026 (Q1FY27), with standalone net profit after tax (PAT) surging 179% year-on-year to ₹287.83 million. This performance significantly outpaced the previous year's figure of ₹103.42 million and was underpinned by a robust 56% year-on-year expansion in revenue from operations to ₹6,982.96 million. The strong bottom-line growth reflects improved operational efficiency and successful pass-through of higher raw material costs to finished goods, driven by better demand across its integrated chemical divisions.
The Board of Directors approved the unaudited financial results on August 5, 2026, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. M/s. B N P S & Associates LLP, the Statutory Auditors of the Company, issued limited review reports for both standalone and consolidated results. Consolidated net profit also increased sharply to ₹303.79 million, up from ₹95.33 million in the prior year quarter, while consolidated revenue reached ₹7,090.41 million.
Financial Performance Highlights
Revenue from operations stood at ₹6,982.96 million for the quarter, compared to ₹5,770.99 million in the previous quarter and ₹4,448.47 million in the same quarter last year. Total income for the period reached ₹7,035.75 million. On the expense side, total expenses were recorded at ₹6,648.34 million, driven primarily by cost of materials consumed at ₹4,811.13 million and other expenses at ₹1,779.35 million. Profit before tax was ₹387.41 million, against which tax expense amounted to ₹99.58 million.
| Metric | Q1 FY27 (₹ Mn) | Q4 FY26 (₹ Mn) | Q1 FY26 (₹ Mn) | YoY Change |
|---|---|---|---|---|
| Revenue from Operations | 6,982.96 | 5,770.99 | 4,448.47 | +56.9% |
| Total Income | 7,035.75 | 5,789.61 | 4,470.91 | +57.4% |
| Total Expenses | 6,648.34 | 5,421.49 | 4,332.85 | +53.5% |
| Profit Before Tax | 387.41 | 368.12 | 138.06 | +180.6% |
| Net Profit After Tax | 287.83 | 305.24 | 103.42 | +178.3% |
| EPS (Basic) | ₹2.29 | ₹2.43 | ₹0.82 | +179.3% |
Consolidated EBITDA grew year-on-year to ₹692 million, with the EBITDA margin at 9.91% compared to 11.2% in Q1FY26, reflecting the impact of higher raw material costs linked to crude oil prices.
Segmental Growth Drivers
The investor presentation highlighted that the company's integrated model and cascading effect resulted in better realization across divisions. Revenue from Dye Intermediates grew by 44% year-on-year to ₹2,166 million, driven by improved realization and volume. Dyestuff revenue grew by 23% year-on-year to ₹1,490 million, where improved realization helped absorb raw material pressure. Revenue from Basic Chemicals surged by 89% year-on-year to ₹839 million, mainly due to an increase in its main raw material, Sulphur. The Chlor Alkali business reported revenue of ₹870 million, a modest growth of 3% year-on-year.
Additionally, Saykha's Benzene downstream division started contributing to the topline during the quarter, with management expecting gradual revenue growth from this segment. On the international front, Sener Boya, the Turkish subsidiary, reported revenue growth of 41% and a PAT of ₹22 million for Q1FY27. In contrast, the Chinese and Indonesian subsidiaries remained subdued during the quarter.
What the Numbers Show
The most notable aspect of this quarter's performance is the disproportionate rise in profitability relative to revenue growth. While revenue increased by approximately 57% year-on-year, net profit surged by nearly 179%. This divergence suggests improved operational efficiency or margin expansion, despite the contraction in EBITDA margin. The recognition of ₹25.71 million in SGST incentive income under the Punjab Industrial Incentive Scheme contributed to revenue, subject to final verification by the competent authority. The company's ability to pass on price effects due to better demand has been critical in maintaining margins amidst rising crude oil-linked raw material costs.
Key Disclosures and Notes
The financial results include the impact of Ind AS 29 – 'Accounting of Hyperinflationary economies' applied to subsidiaries in Turkey. A restatement impact of ₹13.10 million was debited to other expenses in the consolidated results for the quarter. The Group noted that four subsidiaries' interim financial information had not been reviewed by their auditors but were deemed not material to the Group, with total income of ₹91.55 million and a net loss of ₹1.84 million. Two other subsidiaries' results were reviewed by other auditors, reflecting total income of ₹73.57 million and net profit of ₹21.47 million.
Historical Stock Returns for Bodal Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.99% | +31.67% | +38.89% | +104.13% | +44.83% | -10.03% |
How sustainable is Bodal Chemicals' current margin expansion strategy given the persistent volatility in crude oil-linked raw material costs?
What specific operational improvements or capacity expansions are driving the 89% surge in Basic Chemicals revenue, and will this growth trajectory continue into Q2 FY27?
To what extent will the implementation of Ind AS 29 for hyperinflationary economies impact future consolidated financial reporting and comparability for international subsidiaries like Sener Boya?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
